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Hypoalbuminemia and risk of death in pediatric patients with can stimulate growth and cognitive development [1–3].
end-stage renal disease. However, little is known about the effect of nutritional
Background. Although serum albumin is a marker for mal- status on survival within the pediatric ESRD population.
nutrition and associated with a higher mortality in adult pa- Data from adult dialysis patients suggest that indica-tients with end-stage renal disease (ESRD), the risk of death
tors of nutritional status are independently associatedassociated with serum albumin is unknown in pediatric patients
with morbidity and mortality [4–6]. Furthermore, pro-with ESRD. We evaluated the association between serum albu-
min and death among pediatric patients initiating dialysis. tein-energy malnutrition in these patients is highly preva-
Methods. Data from the United States Renal Data System lent and is one of the strongest predictors of morbidity
(USRDS) were used to identify all patients under the age of 18 and mortality [7–9]. Because of these nutritional concerns,
who initiated dialysis between January 1, 1995 and December the K/DOQI Nutritional Guidelines recommend includ-31, 1998. Using the Cox proportional hazards models, the associ-
ing serum albumin as part of the routine assessment ofation between serum albumin obtained 45 days prior to dialysis
nutritional status in maintenance dialysis patients. Thereinitiation and death was estimated, controlling for demographic
is a large body of literature that defines normal serumfactors, dialysis modality, and anthropometric measures.
Results. Of 1723 patients included in the analysis, there were albumin values, characterizes the multiple factors affect-
93 deaths over 2953 patient-years of observation. The multivar- ing serum albumin concentrations, and demonstrates the
iate analysis demonstrated that each 1 g/dL difference in relationship between serum albumin concentrations and
serum albumin between patients was associated with a 54%
outcomes [10]. Hypoalbuminemia when present at thehigher risk of death [adjusted relative risk (aRR), 1.54; 95%
time of initiation of chronic dialysis as well as during theconfidence interval (CI), 1.15 to 1.85; P  0.002]. This was
course of maintenance dialysis is highly predictive ofindependent of glomerular causes for their ESRD and other
potential confounding variables. future mortality risk in adult patients with ESRD [4–6,
Conclusions. Pediatric patients initiating dialysis with hypo- 8, 9, 11, 12].
albuminemia are at a higher risk for death. This finding persists Pediatric patients with ESRD have a significantly higher
after adjusting for glomerular causes for ESRD and other po- risk of death compared to the general pediatric popula-tential confounding variables. Low serum albumin at dialysis
tion [13]. Though the etiology of this increased risk ofinitiation is an important marker of mortality risk in pediatric
death is likely multifactorial, nutritional status may playESRD patients.
an important role. Although we have shown that abnor-
mal anthropometric measurements are associated with
risk of death, there are no studies characterizing the rela-The prevention of malnutrition is of paramount con-
tionship between serum albumin and mortality amongcern in the care of pediatric patients with end-stage renal
pediatric patients with renal failure [13]. We used datadisease (ESRD). Data from the pediatric ESRD litera-
from the United States Renal Data System (USRDS) toture have shown that improving nutritional management
estimate the risk of all-cause mortality associated with
serum albumin measured within 45 days of initiating
dialysis among pediatric patients.Key words: nutrition, serum albumin, children, dialysis, outcome, mor-
tality risk, malnutrition, protein-energy malnutrition.
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dence, prevalence, treatment, morbidity and mortality no), treatment modality, height SDS, weight SDS, and
serum albumin.of ESRD patients residing in the United States. A more
in-depth discussion of the USRDS data collection tech- Patients were followed in the study until they had the
event of interest, death from any cause, or were censoredniques can be found elsewhere [14]. We identified all
due to a loss to follow-up or to termination of the studypatients younger than 18 years of age who indicated
(July 31, 1998). Patients were not censored at the timeinitiation of dialysis by submitting a HCFA 2728 Medical
of transplant because a major assumption of the CoxEvidence Form between January 1, 1995 and July 31,
proportional hazards model requires that censoring, or1998 (N  1937).
removing patients from the analysis, is not associated
Data collection with the end point, in this case, death [16]. Removing
patients from the analysis at the time of transplant mayData abstracted from the Medical Evidence Form for
have violated this assumption, because transplanted pa-this study included: date of birth, date of dialysis ini-
tients are generally healthier and less likely to die thantiation, gender, race (white, black, and other), primary
those remaining on dialysis [17–19]. In order to accountcause of ESRD (congenital/inherited diseases, glomeru-
for changes in ESRD treatment modality over time andlar diseases, vasculitic/interstitial disease, nephrotoxic/
retain individuals that were subsequently transplantedtumor-related, and other), and baseline serum albumin.
over the course of the study, treatment modalities (he-The reported values for serum albumin were obtained
modialysis, peritoneal dialysis, transplant) were modeledand reported within 45 days prior to the first dialysis for
as time-dependent covariates [16, 17, 20].ESRD. The most recent value for height and weight
Adjustment factors were included in the model if theyprior to dialysis were used for the analysis. Baseline
were shown to be associated with death, thought to con-treatment modality and subsequent modality changes
found the relationship between albumin and death, orwere abstracted from the USRDS Treatment History
considered an adjustment factor a priori. All adjustmentStandard Analysis File (SAF).
variables used in the model satisfied the assumption of
Outcome assessment proportional hazards. The proportionality of hazards for
all models was verified via formal hypothesis tests andSurvival status and primary cause of death were ob-
visual inspection of the scaled Schoenfeld residuals.tained from the Patients SAF of the USRDS and linked
Hazard ratios obtained from the analysis were usedto patients in this cohort via unique patient identifiers
to estimate the adjusted and unadjusted relative risk ofassigned to each individual by the USRDS. Patient sur-
death. After adjustment for other covariates in the finalvival status is periodically updated in the Patients’ SAF
model, the adjusted relative risks (aRR) were interpre-and was complete through July 1998.
ted as the risk for death among pediatric ESRD patients
Statistical analysis associated with each variable of interest. The estimated
standard error of the coefficients from the Cox regressionTo standardize height, weight, and body mass index
analysis was used to estimate confidence intervals (CI’s)(BMI; defined as weight in kilograms per meter of height
for the aRR. The threshold of statistical significance wassquared) with respect to age and sex, the measurements
set to 0.05. Results were reported as aRRs with 95% CI’swere reported as standard deviation scores (SDS), as
and two-tailed P values. Computations were performeddescribed previously [13]. Normative data were obtained
using S-PLUS (Mathsoft, Seattle, WA, USA).from the Third National Health and Nutrition Examina-
tion Survey (NHANES III), a cross-sectional survey of
the United States (US) civilian, non-institutionalized RESULTS
population, aged two months and older [15]. SDS were
Between January 1, 1995 and December 31, 1998, 1937calculated using the following formula:
pediatric patients initiated dialysis. Of these patients,
1723 patients had a serum albumin level available forSDS  (ESRD patient measurement) (mean US value for age and sex)
(standard deviation of mean US value for age and sex)
analysis. Two hundred fourteen patients whose serum
albumin data were missing were excluded. Characteris-The resulting SDS reflects the number of standard
deviations the measurement for an ESRD patient lies tics of the study population and those excluded from the
analysis are summarized in Table 1. Comparing patientsabove or below the mean value in the general population
matched by age and gender. with and without serum albumin data, there were no
differences between the groups with regard to gender,For selected analyses, differences between patient
groups were compared using chi-square tests for categor- race, cause of ESRD, or proportion of deaths. However,
patients with missing data were more likely to be in theical variables. The risk of all-cause mortality was esti-
mated using a Cox proportional hazards model, adjusting 15 to 18 year age group. Comparing patients with a nor-
mal serum albumin to those with a serum albumin 3.5for age, sex, race, glomerular cause of ESRD (yes vs.
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Table 1. Characteristics of the study population stratified by baseline albumina
Characteristic Albumin 3.5 g/dL Albumin 3.5 g/dL Missing albumin
Total patients 987 (100%) 736 (100%) 214 (100%)
Sex
Male 502 (50.9%) 443 (60.2%) 111 (51.9%)
Age
0 to 2 years 89 (9%) 53 (7.2%) 13 (6.1%)
3 to 5 years 128 (13.0%) 62 (8.4%) 20 (9.3%)
6 to 14 years 393 (39.8%) 341 (46.3%) 76 (35.5%)
15 to 18 years 377 (38.2%) 280 (38.0%) 105 (49.1%)
Race
White 556 (56.3%) 456 (62.0%) 126 (58.9%)
Black 294 (29.8%) 189 (25.7%) 63 (29.4%)
Other 137 (13.9%) 91 (12.4%) 25 (11.7%)
Height SDSb
Less than 2 350 (36.5%) 298 (41.4%) 78 (36.8%)
2 to 0 404 (42.1%) 314 (43.6%) 81 (38.2%)
Greater than 0 205 (21.4%) 108 (15.0%) 53 (25.0%)
Weight SDSb
Less than 2 88 (9.2%) 64 (8.8%) 13 (6.2%)
2 to 0 680 (71.0%) 542 (74.9%) 141 (67.5%)
Greater than 0 190 (19.8%) 118 (16.3%) 55 (26.3%)
BMI SDSb
Less than 2 25 (2.7%) 22 (3.1%) 3 (1.5%)
2 to 0 630 (67.0%) 470 (65.9%) 135 (65.5%)
Greater than 0 286 (30.4%) 221 (31.0%) 68 (33.0%)
Cause of ESRD
Glomerular diseases 524 (53.1%) 195 (26.5%) 101 (47.2%)
Congenital/inherited 234 (23.7%) 356 (48.4%) 64 (29.9%)
Vasculitis/interstitial diseases 61 (6.2%) 80 (10.9%) 14 (6.5%)
Nephrotoxic/tumor related 18 (1.8%) 8 (1.1%) 2 (0.9%)
Other 83 (8.4%) 44 (6.0%) 20 (9.3%)
Unknown 67 (6.8%) 53 (7.2%) 13 (6.1%)
Cause of death (N103)
All causes 69 24 10
Cardiovascular 14 (20.3%) 4 (16.7%) 1 (10.0%)
Infection 14 (20.3%) 2 (8.3%) 3 (30.0%)
Cerebrovascular/anoxia 3 (4.3%) 2 (8.3%) 1 (10.0%)
Hemorrhage 1 (1.4%) 1 (4.2%) 0 (0%)
Gastrointestinal 3 (4.3%) 1 (4.2%) 0 (0%)
Fluid overload 1 (1.4%) 0 (0%) 2 (20.0%)
Neoplasm 5 (7.2%) 3 (12.5%) 0 (0%)
Other 28 (40.6%) 11 (45.8%) 3 (30.0%)
a Statistics presented are frequency (%)
b Numbers may vary from total due to missing data
g/dL, there were no significant differences by age, gen-
der, race, height, weight, or BMI. Hypoalbuminemic pe-
diatric patients were more likely to have glomerular dis-
eases as their cause of ESRD compared to patients who
were not hypoalbuminemic (53.1 vs. 26.5%; P 0.0001).
Among the pediatric ESRD patients in the study, there
were 93 deaths over 2953 patient-years of observation.
This yielded a mortality rate of 31.5 deaths per 1000
patient-years. The mortality rates stratified by serum
albumin are presented in Figure 1. The risk of pediatric
ESRD death was inversely related to the level of serum
albumin. From the highest to lowest categories of serum
albumin, the rate of death per 1000 patient-years of ob-
servation was 18.4 for patients with a serum albumin of
3.5 g/dL, 33.2 for patients with a serum albumin be-
tween 3.5 to 3.1 g/dL, and 46.9 for patients with a serum Fig. 1. Pediatric end-stage renal disease (ESRD) mortality rate per
1000 person-years by level of serum albumin.albumin between 3.0 to 2.1 g/dL. The mortality rate was
Wong et al: Hypoalbuminemia and death in pediatric ESRD 633
Table 2. Cox regression results analysis: Unadjusted and adjusted estimates for relative risk of death
Unadjusted Adjusteda
Observed Deaths per Relative risk Relative risk
Covariate deaths 1000 patient-years (95% CI) P value (95% CI) P value
Sex
Female 49 33.8 1.0 1.0
Male 54 28.8 0.87 (0.59, 1.27) 0.46 0.82 (0.53, 1.27) 0.37
Age 0.95 (0.92, 0.99) 0.009 0.96 (0.91, 1.00) 0.07
0 to 2 years old 16 42.5 1.0 1.0
3 to 14 years old 53 30.8 0.52 (0.30, 0.91) 0.02 0.39 (0.21, 0.75) 0.005
15 to 18 years old 34 26.4 0.45 (0.25, 0.82) 0.009 0.39 (0.19, 0.80) 0.01
Race
White 58 29.5 1.0 1.0
Black 31 33.4 1.12 (0.72, 1.73) 0.61 1.20 (0.72, 2.00) 0.47
Other 14 32.7 1.10 (0.61, 1.98) 0.75 0.97 (0.50, 1.91) 0.94
Treatment modality
HD 39 37.2 1.0 1.0
PD 40 35.2 0.94 (0.60, 1.46) 0.78 0.79 (0.47, 1.30) 0.35
Transplant 13 11.9 0.29 (0.15, 0.57) 0.001 0.32 (0.16, 0.66) 0.002
Primary cause of ESRD
Not GN related 58 30.6 1.0 1.0
GN related 45 31.6 1.03 (0.70, 1.53) 0.86 0.86 (0.52, 1.42) 0.56
Height SDSb 1.30 (1.18, 1.43) 0.001 1.28 (1.14, 1.43) 0.001
Less than 3 42 66.5 1.0 1.0
3 to 1 29 21.3 0.32 (0.2, 0.51) 0.001 0.35 (0.21, 0.59) 0.001
Greater than 1 27 21.6 0.32 (0.2, 0.52) 0.001 0.23 (0.10, 0.54) 0.001
Weight SDSc 0.005 0.12
Less than 1 56 36.5 1.0 1.0
1 to 3 41 25.1 0.69 (0.46, 1.03) 0.07 1.11 (0.65, 1.89) 0.70
Greater than 3 3 45.3 1.24 (0.39, 3.95) 0.72 2.75 (0.79, 9.53) 0.11
Albumin g/dLd 1.54 (1.23, 1.92) 0.001 1.47 (1.15, 1.85) 0.002
3.5 g/dL or greater 24 18.4 1.0 1.0
Less than 3.5 g/dL 69 41.8 2.25 (1.41, 3.58) 0.001 1.90 (1.16, 3.10) 0.01
a Adjusted for age, gender, race, treatment modality, glomerular cause of ESRD, height SDS, weight SDS, and albumin
b Modeled as a continuous variable decreasing by 1 SDS
c Weight SDS was modeled with a quadratic term; corresponding P values apply to a joint likelihood ratio test for both the linear and quadratic term
d Modeled as a continuous variable decreasing by 1 g/dL
highest at 48.7 deaths per 1000 patient-years among pa- in weight SDS, either too high or too low, were associated
with a higher risk of death. However, the evaluation oftients initiating dialysis with a serum albumin2.1 g/dL.
Univariate relative risks of death associated with the BMI SDS demonstrated no association with risk of death
in this cohort of pediatric ESRD patients (data not shown).covariates of interest are presented in Table 2. There
were no differences in risk of death by sex or race. Risk Without adjustment for other factors, serum albumin
determined within 45 days of initiating dialysis was in-of death was inversely proportional to age. The youngest
patients from 0 to 2 years of age had the highest rate of versely associated with risk of death. Each 1 g/dL lower
serum albumin was associated with an estimated 54%mortality at 42.5 deaths per 1000 patient-years. Com-
pared to the youngest age group, patients initiating dial- higher risk of death (RR, 1.54; 95% CI, 1.23 to 1.92; P
0.001). When patients were divided into two groups byysis at 3 to 14 years of age had a 48% lower risk of death
(RR  0.52; 95% CI 0.30 to 0.91; P  0.02). Those serum albumin, patients with a serum albumin3.5 g/dL
had over a twofold greater risk of death compared pa-initiating dialysis between 15 and 18 years of age had a
54% lower risk of death compared to patients in the tients with a normal serum albumin3.5 g/dL (RR, 2.25;
95% CI, 1.41 to 3.58; P  0.001).youngest age category (RR  0.45; 95% CI 0.25 to 0.82;
P  0.009). Patients who were transplanted had an esti- After adjustment for age, gender, race, treatment
modality, glomerulonephritis as a cause of ESRD, heightmated 81% lower risk of death compared to hemodialy-
sis patients (RR  0.29; 95% CI 0.15 to 0.57; P  0.001). SDS and weight SDS, serum albumin continued to be a
significant predictor for death (Table 2). Comparing twoCompared to patients who did not have a glomerular
cause of ESRD, patients with a glomerular cause of patients who are similar for the above factors with the
exception of serum albumin, the patient initiating dialysisESRD did not have a higher risk of death (RR, 1.03; 95%
CI, 0.70 to 1.53; P 0.86). Analyzing anthropometric mea- with a lower serum albumin by 1 g/dL was estimated to
experience a 47% greater risk of death (aRR, 1.47; 95%sures, we found an inverse association between height
SDS and pediatric risk of death. Additionally, extremes CI, 1.15 to 1.85; P 0.002). After adjusting for the above
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factors, patients with a serum albumin below 3.5 g/dL analysis would have demonstrated no association be-
tween serum albumin and risk of death. However, evenhad an estimated 90% greater risk of death compared
to patients with a serum albumin level 3.5 g/dL (aRR, after including glomerular cause of ESRD in the multi-
variate analysis, a low serum albumin was still found to1.90; 95% CI, 1.16 to 3.10; P 0.01). Age-specific interac-
tions with serum albumin were not statistically significant be associated with a higher risk of death.
Our results demonstrate that low serum albumin at(P 0.43), nor were modality-specific interactions (albu-
min * HD referent; albumin * PD, P 0.16; albumin * initiation of dialysis in the pediatric ESRD population
is a marker for poor outcome, independent of othertransplant, P  0.88).
The multivariate analysis demonstrated other signifi- known risk factors for death. Although there are no
comparable data among pediatric ESRD patients, ourcant risk factors associated with pediatric ESRD survival.
In addition to albumin, age, ESRD modality, and height findings are consistent with the preponderance of studies
in the adult dialysis population demonstrating that lowSDS continued to be associated with mortality. Com-
pared to the youngest group of patients (0 to 2 years of serum albumin is a risk factor for death [5, 7–9, 11, 21].
The magnitude of the relative risk of death associatedage) who were at the highest risk for death, older children
in both groups 3- to 14-year-olds and 15- to 18-year-olds with different levels of serum albumin in our study is
similar to values reported by Leavey et al [9] and Iseki ethad an estimated 61% lower risk for death (respectively,
aRR, 0.39; 95% CI, 0.21 to 0.75; P 0.005 and aRR, 0.39; al [5], but lower in magnitude compared to the estimated
two- to seven-fold higher risk of death for patients with95%CI, 0.19 to 0.80; P 0.01). Transplanted patients had
a 68% lower mortality risk compared to the risk for a serum albumin3.5 g/dL reported by Lowrie and Lew
[7, 22]. The differences among the studies regarding thehemodialysis patients (aRR, 0.32; 95% CI, 0.16 to 0.66;
P 0.002). There was no significant difference in mortal- magnitude of the relative risk for death associated with
serum albumin may be due to differences in the studyity risk of peritoneal dialysis patients compared to hemo-
dialysis patients. Height SDS was inversely related to design or analytic methods. For example, the variability
or imprecision in the determination of serum albuminmortality risk. For each decrement in height SDS by 1
may attenuate the estimated magnitude of the risk forthe adjusted relative risk for death was estimated to be
death associated with low serum albumin in our study28% higher (aRR, 1.28; 95% CI, 1.14 to 1.43; P 0.001).
[23]. The determination of serum albumin was not per-After adjustment, weight SDS was not significantly asso-
formed by one single laboratory for the whole cohort,ciated with pediatric ESRD mortality. The association
but by multiple laboratories for patients in this cohort.between glomerular cause of ESRD and risk of death
Furthermore, as an additional source of variation, noin the multivariate analysis was not significant.
single uniform method was used for the measurement
of serum albumin. The technique to measure serum albu-
DISCUSSION min was not requested for the HCFA 2728 form and
The results of this study demonstrate that hypoalbumi- thus the method for serum albumin determination was
nemic pediatric patients who are initiating dialysis have not available in the data. Recent studies have examined
a higher risk of death compared to those starting dialysis the variation in measurement of serum albumin com-
with a normal serum albumin. These findings are inde- monly performed by two different analytic methods: bro-
pendent of conditions such as glomerulonephritis in mocresol green (BCG) and bromocresol purple (BCP)
which proteinuria may contribute to hypoalbuminemia, [24, 25]. It has been established that for a given measure-
and other potentially confounding factors. Low serum ment of serum albumin the BCG method will report a
albumin is an important marker for mortality risk in higher value compared to BCP. Therefore, a patient
pediatric ESRD patients. with hypoalbuminemia might be misclassified as having
Even though glomerular cause of ESRD was not asso- a higher serum albumin value if the serum albumin was
ciated with higher risk of death, we included glomerular determined by the BCG analysis. How might such a
associated diseases as an a priori adjustment factor in difference in serum albumin determination affect the
the multivariate analysis. By adjusting for the glomerular results of this study? Assuming that some patients with
causes of ESRD, we in essence evaluated the association hypoalbuminemia might have been misclassified to
between risk of death and serum albumin among groups groups with a higher serum albumin, the magnitude of
of patients with glomerular causes of ESRD and among the “true” relative risk for death associated with hypoal-
groups who did not have a glomerular cause of ESRD. buminemia would be underestimated by the analysis due
Hypothetically, if the increased risk of death was a mani- to this source of variability. Another possible explana-
festation of the underlying renal disease and hypoalbu- tion for the differences in the estimate of the relative
minemia was a marker for this condition, then the ad- risk between serum albumin and mortality may lie in
justment for glomerular causes of ESRD would have the differences between adult and pediatric ESRD popu-
lations. Changes in serum albumin may have a greateraccounted for the potential bias and the multivariate
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magnitude of difference in the associated risk for adults ence on subsequent survival after dialysis initiation. Hy-
poalbuminemia may be influenced by multiple factorsdue to co-morbid factors—such as smoking, diabetes,
and coronary artery disease—which are not generally during chronic renal insufficiency. Pediatric patients with
chronic renal insufficiency are at risk for malnutritionpresent in children. Despite the differences, the above
studies demonstrate that low serum albumin is associated and poor growth [3, 30–32]. Malnutrition in this cohort
might be indicated by hypoalbuminemia. The uremicwith poor outcome in adult and pediatric patients with
ESRD. milieu of chronic renal insufficiency is characterized by
several factors leading to protein-energy malnutrition andConsistent with previously published data, we identi-
fied other known risk factors for death in the pediatric hypoalbuminemia including anorexia, acidosis, and alter-
ations in metabolism secondary to hormonal derange-ESRD population. We demonstrated that the youngest
patients initiating dialysis had the highest rate of death, ments [33–37]. Furthermore, hypoalbuminemia may re-
flect other co-morbid conditions associated with eitherconfirming previous observations [26–29]. Recent reports
have demonstrated that in the youngest patients under- decreased synthesis of serum albumin due to inflamma-
tion, infection, or liver disease; or increased losses sec-going dialysis co-morbid non-renal disease, in particular
pulmonary hypoplasia, was a risk factor for death [27, 29]. ondary to persistent proteinuria [38].
Although this study demonstrates a strong associationThe findings of our study demonstrates that low serum
albumin is also a risk factor for death in this young ESRD between hypoalbuminemia and poor outcome, the patho-
physiologic mechanism between the two remain unclear.population. In our study, age-specific interaction terms
with serum albumin were used to test if the association A number of investigators have suggested that pro-inflam-
matory cytokines play a key role in both mediating hypo-between low serum albumin and poor outcome depended
on the age of the patient. This analysis showed no signifi- albuminemia and increasing atherogenic processes that
may increase the risk of cardiovascular-specific eventscant differences by age, suggesting that the relationship
between a low serum albumin and higher risk of death [12, 39–42]. Other mechanisms that have been proposed
include generalized immunologic dysfunction and chronicwere no different in young children compared to other
age groups. A study using the data from Pediatric Growth inflammation, decreased bioactivity of insulin-like growth
factor-1, and altered drug kinetics [13, 33, 43–47]. Addi-and Development Special Study of the USRDS demon-
strated that height SDS was inversely associated with tional studies are warranted to define the causal pathway
contributing to mortality in pediatric ESRD patients withrisk of death [13]. The analysis in the present study dem-
onstrated that height SDS and serum albumin were inde- hypoalbuminemia.
We acknowledge the marked differences in the naturalpendently associated with death. Even though height
SDS was included as an adjustment factor in the analysis, history of disease between dialysis and transplant modal-
ities. However, excluding transplant recipients would havelow serum albumin remained an independent risk factor
for death. This raises the possibility that factors contrib- limited the generalizability of our results. In addition, cen-
soring subjects at the time of transplant from our analysisuting to growth impairment and hypoalbuminemia in this
population may act through separate pathophysiologic would have biased our results [18, 19, 48]. Healthier di-
alysis patients are more likely to have a normal serummechanisms contributing independently to the risk of
death. albumin and may be preferentially selected for trans-
plantation. If these patients were censored at the timeSerum albumin obtained at initiation of dialysis is a
marker for children who are at risk for poor outcome re- of transplantation, they would no longer accumulate time
at risk and therefore fewer deaths would be observedgardless of subsequent renal replacement modality. This
single measurement of serum albumin remained strongly among patients with higher albumin. Therefore, dialysis
patients who were subsequently transplanted after theassociated with risk of death, even after adjustment for
renal replacement modality. Furthermore, the modality- start of the study were not censored, but remained in
the study.specific interaction terms with serum albumin demon-
strated no significant differences, suggesting that the To account for the possibility of bias due to subsequent
transplantation, it was necessary to adjust for renal re-magnitude of association between serum albumin at initi-
ation of dialysis and risk of death was similar among placement modality. We were able to adjust for the in-
herent differences between dialysis and transplantationpediatric patients treated with peritoneal dialysis, hemo-
dialysis, and renal transplantation. These findings suggest by using time-dependent covariates [16, 17, 20]. Time-
dependent covariates allow patients to contribute timethat low serum albumin at the initiation of dialysis is an
important indicator of subsequent mortality risk among at risk for death for a given modality as they changed
from one form of renal replacement therapy to another,pediatric ESRD patients.
Given the prognostic value of serum albumin at dial- more precisely modeling the risk for death associated
with each modality.ysis initiation, factors that determine hypoalbuminemia
during chronic renal failure may have a significant influ- Given that this is an observational study, there may
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2. Polinsky MS, Kaiser BA, Stover JB, et al: Neurologic develop-be unmeasured factors that could introduce bias into the
ment of children with severe chronic renal failure from infancy.
analysis. Furthermore, a selection bias may have been Pediatr Nephrol 1:157–165, 1987
3. Warady BA, Kriley M, Lovell H, et al: Growth and developmentintroduced since only patients who had a documented
of infants with end-stage renal disease receiving long-term perito-serum albumin were included in the analysis. Eleven
neal dialysis. J Pediatr 112:714–719, 1988
percent of the patients in the original cohort were missing 4. Avram M, Mittman N, Bonomini L, et al: Markers for survival in
dialysis: A seven-year prospective study. Am J Kidney Dis 26:209–values for serum albumin and thus were excluded from
219, 1995the analysis. Those who were missing serum albumin were
5. Iseki K, Uehara H, Keizo N, et al: Impact of the initial levels of
more likely to be of older age, between 15 and 18 years. laboratory variables on survival in chronic dialysis patients. Am
J Kidney Dis 28:541–548, 1996Therefore, the findings of the analysis may be more gener-
6. Owen W, Lew N, Liu Y, et al: The urea reduction ratio andalizable to a younger population of patients initiating
serum albumin concentration as predictors of mortality in patients
dialysis. Furthermore, pediatric-specific co-morbid con- undergoing hemodialysis. N Engl J Med 329:1001–1006, 1993
7. Lowrie E, Huang W, Lew N: Death risk predictors among perito-ditions are not reported to the USRDS on the HCFA
neal dialysis and hemodialysis patients: A preliminary comparison.2728 Medical Evidence Form and thus were not available
Am J Kidney Dis 26:220–228, 1995
for this study. Lastly, only the serum albumin at dialysis 8. Canada–USA Peritoneal Dialysis Study Group: Adequacy of dial-
ysis and nutrition in continuous peritoneal dialysis: Associationinitiation was available in the data, hence it was not pos-
with clinical outcomes. J Am Soc Nephrol 7:198–207, 1996sible to determine if subsequent changes in serum albu-
9. Leavey SF, Strawderman RL, Jones CA, et al: Simple nutritional
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